Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 31
Selected: 0
NCT IDTitle
NCT01940991Efficacy and Safety of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines
NCT06133491Open Label, 6-month Study for High Frequency and Chronic Migraine,
NCT01818076Open Label Study to Assess Long-term Safety of Repeat Administration of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines
NCT03617367Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-OLS)
NCT02973269DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis
NCT01124565Safety Study of Two Repeat Doses of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults
NCT03004248Safety of Single and Repeat Treatments of DaxibotulinumtoxinA for Injection for Treatment of Moderate to Severe Glabellar Lines
NCT04259086Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Upper Facial Lines
NCT03014622Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines
NCT03014635Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines
NCT04846530Teosyal RHA® Histology and Intradermal Implantation Evaluation Study
NCT00888914Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
NCT02706795Dose-escalating Safety and Preliminary Efficacy of DaxibotulinumtoxinA for Injection in Cervical Dystonia
NCT00968825Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
NCT00884234Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
NCT01064518Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults
NCT03911102Efficacy and Safety of Increasing Doses of DaxibotulinumtoxinA for Injection (DAXI for Injection) in the Treatment of Moderate or Severe Lateral Canthal Lines
NCT06411002Phase 2a Study of DaxibotulinumtoxinA-lanm for Injection in Dynamic Forehead Lines and Glabellar Lines
NCT03821402Efficacy and Safety of DaxibotulinumtoxinA for Injection for the Treatment of Adult Upper Limb Spasticity
NCT02303002Efficacy and Safety of Botulinum Toxin Type A for Injection to Treat Glabellar Lines
NCT00968942Efficacy and Safety Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
NCT02580370Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Lateral Canthal Lines
NCT02565732Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Primary Axillary Hyperhidrosis
NCT01776606Efficacy and Safety Study of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines
NCT03825315DaxibotulinumtoxinA for Injection for the Treatment of Plantar Fasciitis
NCT01124552A 4-Arm Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults
NCT03137407Phase 2 DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis
NCT03608397Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-1)
NCT06154070An Open Label, Study of DaxibotulinumtoxinA for Migraine Prevention
NCT03786770Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Forehead Lines (Frontalis)
NCT00907387Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines